Bilaketaren emaitzak - Jean‐Pierre Bronowicki

Findu emaitzak
  1. 1
    The Challenge of Prognosis and Staging for Hepatocellular Carcinoma

    The Challenge of Prognosis and Staging for Hepatocellular Carcinoma nork Jorge A. Marrero, Masatoshi Kudo, Jean-Pierre Bronowicki

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort

    Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort nork Xavier Adhoute, Guillaume Pénaranda, Jean‐Pierre Bronowicki, Jean‐Luc Raoul

    Argitaratua 2014
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

    Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases nork Julien Loubinoux, Jean‐Pierre Bronowicki, Inês A. C. Pereira, Jean-Louis Mougenel, Alain Le Faou

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

    Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study nork Shannon Ferrante, Jagpreet Chhatwal, Clifford A. Brass, Antoine C. El Khoury, Fred Poordad, Jean-Pierre Bronowicki, Elamin H. Elbasha

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability

    Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability nork Cécile Bastard, Stéphane Audière, Julie Foucquier, Hugo Lorée, Véronique Miette, Jean‐Pierre Bronowicki, Christiane Stern, Cyrielle Caussy, Laurent Sandrin

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin

    Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin nork M. Diago, Mitchell L. Shiffman, Jean‐Pierre Bronowicki, Stefan Zeuzem, M. Rodríguez‐Torres, S. Chris Pappas, Andreas Tietz, David R. Nelson

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges

    The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges nork Marie Müller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin‐Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet, Anthony Lopez

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Rate of natural disease progression in patients with chronic hepatitis C

    Rate of natural disease progression in patients with chronic hepatitis C nork Jean-Pierre Zarski, J. Mc Hutchison, Jean-Pierre Bronowicki, Nathalie Stürm, Richard Garcia‐Kennedy, Enkelejda Hodaj, Brenda Truta, Teresa L. Wright, Robert G. Gish

    Argitaratua 2003
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients

    Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients nork Jean‐Pierre Bronowicki, Denis Vetter, F Dumas, Karim Boudjéma, Robert Bader, Anne-Marie Weiss, Jean-Jacques Wenger, P Boissel, Marc‐André Bigard, Michel Doffoël

    Argitaratua 1994
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections

    Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections nork Graham R. Foster, Christophe Hézode, Jean‐Pierre Bronowicki, Giampiero Carosi, Ola Weiland, Lieselotte Verlinden, Rolf van Heeswijk, Ben Van Baelen, Gastón Picchio, Maria Beumont

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

    Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France nork Jean‐Baptiste Chevaux, Abdelbasset Nani, Abderrahim Oussalah, Véronique Venard, Mouni Bensenane, Arthur Belle, Jean‐Louis Guéant, Marc‐André Bigard, Jean-Pierre Bronowicki, Laurent Peyrin–Biroulet

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

    Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection nork Olivier Hermine, François Lefrère, Jean‐Pierre Bronowicki, Xavier Mariette, Katayoun Jondeau, Virginie Eclache-Saudreau, B Delmas, Françoise Valensi, P. Cacoub, Christian Bréchot, Bruno Varet, Xavier Troussard

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

    Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy nork Jean‐Pierre Bronowicki, Véronique Venard, C. Botté, Nathalie Monhoven, Isabelle Gastin, Laurence Choné, Hervé Hudziak, Bertrand Rhin, Christophe Delanoë, Alain Lefaou, Marc‐André Bigard, P Gaucher

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients

    Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients nork Jean‐Pierre Bronowicki, Catherine Bineau, Pierre Feugier, Olivier Hermine, Nicole Brousse, Frédéric Oberti, Marie-Christine Rousselet, Sébastien Dharancy, Philippe Gaulard, Jean–François Fléjou, Dominique Cazals–Hatem, Eric Labouyrie

    Argitaratua 2003
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results From PROMISE, a Phase III Trial

    869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results Fr... nork Eric Lawitz, Xavier Forns, Stefan Zeuzem, Edward Gane, Jean‐Pierre Bronowicki, Pietro Andreoné, Andrzej Horban, Ashley Brown, Monika Peeters, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Ronald Kalmeijer, Maria Beumont‐Mauviel

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)

    Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) nork Vincent Leroy, Peter Angus, Jean‐Pierre Bronowicki, Gregory J. Dore, Christophe Hézode, Stephen Pianko, Stanislas Pol, Katherine Stuart, Edmund Tse, Fiona McPhee, Rafia Bhore, M.J. Jimenez-Exposito, Alexander Thompson

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3... nork Jason Grebely, Stefan Mauss, Ashley Brown, Jean‐Pierre Bronowicki, Massimo Puoti, David Wyles, Macky Natha, Yanni Zhu, Junming Yang, Bruce Kreter, Diana M. Brainard, Chohee Yun, Val Carr, Gregory J. Dore

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

    Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy nork Stella Maris Martínez, Juliette Foucher, Jean-Marc Combis, Sophie Métivier, Maurizia Rossana Brunetto, Dominique Capron, Marc Bourlière, Jean‐Pierre Bronowicki, Thông Dao, M. Maynard-Muet, Damien Lucidarme, Wassil Merrouche, Xavier Forns, Victor de Lédinghen

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B

    A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B nork Patrick Marcellin, Herve Momméja-Marin, Stephen L. Sacks, George Lau, D. Séréni, Jean‐Pierre Bronowicki, Brian Conway, Christian Trépo, Robert M. Blum, Byung Chul Yoo, Elsa Mondou, J. Sorbel, A. Lynn Snow, Franck Rousseau, Hyo‐Suk Lee

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

    Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial nork Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, Tarik Asselah, Jean‐Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Stefan Mauss, Dominique Larrey, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Schérer, Gerhard Nehmiz, Gerhard Steinmann, Wulf O. Böcher

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: